BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17658465)

  • 1. Promoter polymorphisms of the pigment epithelium-derived factor gene are associated with diabetic retinopathy.
    Iizuka H; Awata T; Osaki M; Neda T; Kurihara S; Inoue K; Inukai K; Kabasawa S; Mori K; Yoneya S; Katayama S
    Biochem Biophys Res Commun; 2007 Sep; 361(2):421-6. PubMed ID: 17658465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C beta (PRKCB1) and pigment epithelium derived factor (PEDF) gene polymorphisms and diabetic retinopathy in a south Indian cohort.
    Uthra S; Raman R; Mukesh BN; Rajkumar SA; Kumari PR; Lakshmipathy P; Gnanamoorthy P; Sharma T; McCarty CA; Kumaramanickavel G
    Ophthalmic Genet; 2010 Mar; 31(1):18-23. PubMed ID: 20141354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
    Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Met72Thr polymorphism of pigment epithelium-derived factor gene and susceptibility to age-related macular degeneration.
    Yamagishi S; Nakamura K; Inoue H; Takeuchi M
    Med Hypotheses; 2005; 64(6):1202-4. PubMed ID: 15823717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of three pigment epithelium-derived factor gene polymorphisms in patients with exudative age-related macular degeneration.
    Mattes D; Haas A; Renner W; Steinbrugger I; El-Shabrawi Y; Wedrich A; Werner C; Schmut O; Weger M
    Mol Vis; 2009; 15():343-8. PubMed ID: 19223990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigment epithelium-derived factor Met72Thr polymorphism in patients with diabetic microangiopathy.
    Yamagishi S; Amano S; Inagaki Y; Okamoto T; Koda Y; Soejima M; Kimura H
    Int J Clin Pharmacol Res; 2002; 22(3-4):67-71. PubMed ID: 12837042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF polymorphisms are associated with severity of diabetic retinopathy.
    Churchill AJ; Carter JG; Ramsden C; Turner SJ; Yeung A; Brenchley PE; Ray DW
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3611-6. PubMed ID: 18441306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes.
    Li H; Louey JW; Choy KW; Liu DT; Chan WM; Chan YM; Fung NS; Fan BJ; Baum L; Chan JC; Lam DS; Pang CP
    Mol Vis; 2008 Sep; 14():1698-704. PubMed ID: 18806884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
    Nam DH; Oh J; Roh JH; Huh K
    Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment epithelium-derived factor is a pericyte mitogen secreted by microvascular endothelial cells: possible participation of angiotensin II-elicited PEDF downregulation in diabetic retinopathy.
    Yamagishi S; Matsui T; Nakamura K; Inoue H
    Int J Tissue React; 2005; 27(4):197-202. PubMed ID: 16440585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
    Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
    Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy.
    Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):542-6. PubMed ID: 17973941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
    Langsenlehner T; Langsenlehner U; Renner W; Krippl P; Mayer R; Wascher TC; Kapp KS
    Eur J Cancer; 2008 Jul; 44(11):1572-6. PubMed ID: 18514506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes.
    Awata T; Kurihara S; Takata N; Neda T; Iizuka H; Ohkubo T; Osaki M; Watanabe M; Nakashima Y; Inukai K; Inoue I; Kawasaki I; Mori K; Yoneya S; Katayama S
    Biochem Biophys Res Commun; 2005 Aug; 333(3):679-85. PubMed ID: 15963467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
    Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
    Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum.
    Zarbock R; Hendig D; Szliska C; Kleesiek K; Götting C
    Hum Mol Genet; 2009 Sep; 18(17):3344-51. PubMed ID: 19483196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions.
    Tong JP; Yao YF
    Clin Biochem; 2006 Mar; 39(3):267-76. PubMed ID: 16409998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.